Have just come acrossed this via a very subtle hint from Motley. Impressive performance, list of clients and potential of the new platform that has FDA approval for the whole new market segment (much wider). Hope this forum will become more alive soon![]()
- Forums
- ASX - By Stock
- CGS
- Ann: Cogstate selected as preferred provider for Lilly
CGS
cogstate ltd
Add to My Watchlist
0.61%
!
$1.66

Ann: Cogstate selected as preferred provider for Lilly, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $280.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.68 | $1.62 | $34.96K | 21.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 621 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 2298 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 621 | 1.610 |
7 | 7699 | 1.600 |
3 | 10722 | 1.575 |
1 | 829 | 1.570 |
1 | 1500 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.710 | 10000 | 1 |
1.740 | 1000 | 1 |
1.750 | 1758 | 1 |
1.790 | 1789 | 1 |
1.800 | 9300 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online